You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0806 Rituximab in clinical practice for the treatment of interstitial lung disease refractory to cyclophosphamide in patients with diffuse systemic sclerosis

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Scleroderma, myositis and related syndromes – clinical aspects and treatment
AB0806 Rituximab in clinical practice for the treatment of interstitial lung disease refractory to cyclophosphamide in patients with diffuse systemic sclerosis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Castellví I, Simeon C, Sarmiento M, et al
AB0806 Rituximab in clinical practice for the treatment of interstitial lung disease refractory to cyclophosphamide in patients with diffuse systemic sclerosis
Annals of the Rheumatic Diseases 2013;71:684.